Cadence OTC key facts
- Developer of birth control pills designed to assist in the process of unwanted pregnancy.
- It has raised $63.5M.
- Notable investors include Gratitude Railroad, NJF Capital, Candide Group, Stardust Equity, Soros Economic Development Fund — 14 tracked in total.
- Status: Privately Held (backing).
Who backs Cadence OTC
14+- ·The complete investor list: 14 names
- ·Watch Cadence OTC: the Monday email on marks, rounds and moves
Cadence OTC funding rounds
No funding rounds for Cadence OTC are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Cadence OTC investors
14 investors are on record for Cadence OTC, including Gratitude Railroad, NJF Capital, Candide Group and Stardust Equity.
About Cadence OTC
Developer of birth control pills designed to assist in the process of unwanted pregnancy. The company's product portfolio includes oral contraceptive pills under an over-the-counter (OTC) status and brings OTC emergency contraceptives to convenience stores without any prescription, helping users with the availability of reproductive health options.
- Sector
- Healthcare
- HQ
- Oakland, CA, United States
- Founded
- 2014
- Employees
- 8
- Website
- cadenceotc.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Cadence OTC doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.